A 30 Day Study to Evaluate Efficacy and Safety of Pre-hospital vs. In-hospital Initiation of Ticagrelor Therapy in STEMI Patients Planned for Percutaneous Coronary Intervention (PCI)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Dr Judith Hsia, MD
AstraZeneca
Study Director - Pr Gilles Montalescot
Pitie Salpetriere Hospital
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
96 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Research Site
Algiers, Algeria
- Research Site
Blida, Algeria
- Research Site
Herston, Australia
- Research Site
Southport, Australia
- Research Site
Woolloongabba, Australia
- Research Site
Graz, Austria
- Research Site
Innsbruck, Austria
- Research Site
Vienna, Austria
- Research Site
Halifax, Nova Scotia, Canada
- Research Site
Newmarket, Ontario, Canada
- Research Site
Scarborough Village, Ontario, Canada
- Research Site
Regina, Saskatchewan, Canada
- Research Site
Aalborg, Denmark
- Research Site
Aarhus, Denmark
- Research Site
Odense C, Denmark
- Research Site
Aubervilliers, France
- Research Site
Besançon, France
- Research Site
Boulogne-Billancourt, France
- Research Site
Bourges, France
- Research Site
Bron, France
- Research Site
Châteauroux, France
- Research Site
Corbeil-Essonnes, France
- Research Site
Créteil, France
- Research Site
Dijon, France
- Research Site
Lagny-sur-Marne, France
- Research Site
Le Chesnay, France
- Research Site
Le Coudray, France
- Research Site
Lyon, France
- Research Site
Marseille, France
- Research Site
Massy, France
- Research Site
Melun, France
- Research Site
Montauban, France
- Research Site
Montfermeil, France
- Research Site
Montreuil, France
- Research Site
Neuilly-sur-Seine, France
- Research Site
Nîmes, France
- Research Site
Paris, France
- Research Site
Pessac, France
- Research Site
Quincy-sous-Sénart, France
- Research Site
Rouen, France
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Sept 2011
- Primary completion
- 30 Nov 2013
- Completion
- 30 Nov 2013
- Last update posted
- 22 Jul 2015
- Registered enrollment
- 1,875
- Registry id
- NCT01347580
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.